Fiche publication
Date publication
février 2026
Journal
Diabetes care
Auteurs
Membres identifiés du Cancéropôle Est :
Pr VERGES Bruno
Tous les auteurs :
Dumortier C, Aho Glele S, Rouland A, Houbachi L, Fourmont C, Vergès B, Petit JM, Bouillet B
Lien Pubmed
Résumé
Diabetic foot ulcer (DFU) is the leading cause of nontraumatic lower-limb amputation (LLA). The impact of sodium/glucose cotransporter-2 inhibitor (SGLT2i) use on LLA is still debated in studies in which the proportion of patients with DFU is unknown. The aim of our study was to determine, specifically in patients with DFU, if the use of an SGLT2i could influence amputation and wound healing.
Référence
Diabetes Care. 2026 02 25;:
